Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (14) , 2477-2480
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pKa: Antibacterial Agents with an Improved Safety ProfileJournal of Medicinal Chemistry, 2012
- 1.2 Importance of Chirality in the Field of Anti-infective Agents2012
- Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerasesBioorganic & Medicinal Chemistry Letters, 2011
- Novel classes of antibiotics or more of the same?British Journal of Pharmacology, 2011
- Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureusClinical Infectious Diseases, 2011
- Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumoniaThe Lancet Infectious Diseases, 2009
- Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II TopoisomerasesAntimicrobial Agents and Chemotherapy, 2008
- Liquid chromatography–tandem mass spectrometric determination of a new antibacterial agent (AVE6971) in human white blood cellsJournal of Chromatography B, 2007
- Dual Targeting of Topoisomerase IV and Gyrase To Reduce Mutant Selection: Direct Testing of the Paradigm by Using WCK-1734, a New Fluoroquinolone, and CiprofloxacinAntimicrobial Agents and Chemotherapy, 2005
- Altered gene expression in human leukemia K562 cells selected for resistance to etoposideBiochemical Pharmacology, 1993